APUS

Conviction 38HealthcareScan · Thu, Sep 24, 2026

Apimeds Pharmaceuticals US, Inc. (APUS) closed at $5.09 (+122.27%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 69, RS Rating 4, -85.5% from its 52-week high, -66.0% year to date. Sector: Healthcare · Pharmaceutical Preparations.

APUS$5.09+122.27%

ResistanceSupportVol 14

Vol MA14 3.12M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Apimeds Pharmaceuticals US, Inc.Pharmaceutical Preparationswww.apimedsus.com ↗

Price5.09

Change+122.27%

Gap+205.24%

Rel volume251.55×

Avg volume2.2M

Avg $ vol10.73M

SMA 202.57

SMA 504.10

SMA 20012.15

Price vs 50+24.28%

Price vs 200-58.11%

MA stackmixed

50/200 cross—

Supertrendup · 3.58

RSI (14)69

MACD hist0.30

MACD crossbull · 2d

Stoch %K / %D50 / 44

ADX (14)22

+DI / −DI61 / 12

RSI divergence—

MACD divergence—

ATR %18.14%

ADR %19.60%

52w high35.06

52w low1.60

From 52w high-85.48%

Above 52w low+218.12%

New 52w highNo

SqueezeOff

Bollinger width148.05%

%B1.16

Donchian pos49.52%

Donchian high8.74

Donchian low1.51

AVWAP (52w high)6.17

vs AVWAP high-17.45%

AVWAP (52w low)5.90

vs AVWAP low-13.77%

OBV trendUp

Chaikin MF (20)-0.75

Today vs 20d251.55×

Avg vol (14d)3.12M

Avg vol (20d)2.2M

Avg $ vol (20d)10.73M

Market cap7.68M

RS Rating4 / 99

RS 3m (vs SPY)-38.58%

RS 6m (vs SPY)-68.46%

RS line new highNo

Trend template2/8

Technical rank41.2

1 week+204.79%

1 month+2.41%

3 months-34.08%

6 months-56.83%

1 year-74.29%

YTD-66.03%

P/E-1.28

P/B0.07

P/S—

P/FCF-0.86

EPS-0.5500

Div yield—

ROE-5.64%

ROA-4.70%

Debt/Eq0.00

Current0.51

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-331.74%

Price target—

Target upside—

Analyst rating—

Institutional3.22%

Ent. value7.42M

Revenue—

Net income-20.17M

Gross profit—

Free cash flow-8.98M

IndustryPharmaceutical Preparations

ExchangeNYSE

Shares out15.09M

Employees7

ListedFri, May 9, 2025

Free float6.85M

Float %54.4%

Short interest19.92K

Days to cover0.1d

Short volume57.2%

Squeeze score27 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction38 / 100

Pattern quality—

Tech rank41.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.21

Support1.56

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APUS

All disclosures →

No recent disclosed trades by Congress in APUS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APUS

No recent insider (Form 4) filings in APUS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in APUS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

APUS

Recent news

Get daily signals & real-time alerts.